Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C23H30N2O4.H2O |
Molecular Weight | 416.5106 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O.[H][C@@]12OC3=C4C(C[C@@]5([H])N(C)CC[C@@]14[C@@]5([H])C=C[C@@H]2O)=CC=C3OCCN6CCOCC6
InChI
InChIKey=VOMHFFCEDKOLBR-RNFKYSJUSA-N
InChI=1S/C23H30N2O4.H2O/c1-24-7-6-23-16-3-4-18(26)22(23)29-21-19(5-2-15(20(21)23)14-17(16)24)28-13-10-25-8-11-27-12-9-25;/h2-5,16-18,22,26H,6-14H2,1H3;1H2/t16-,17+,18-,22-,23-;/m0./s1
DescriptionSources: http://www.ncbi.nlm.nih.gov/pubmed/3283158Curator's Comment: Description was created based on several sources, including http://www.phadia.com/Global/ImmunoCAP%20Allergens/Product%20Leaflets/Product_Leaflet_c261_Pholcodine.pdf
http://www.ncbi.nlm.nih.gov/pubmed/23773349
Sources: http://www.ncbi.nlm.nih.gov/pubmed/3283158
Curator's Comment: Description was created based on several sources, including http://www.phadia.com/Global/ImmunoCAP%20Allergens/Product%20Leaflets/Product_Leaflet_c261_Pholcodine.pdf
http://www.ncbi.nlm.nih.gov/pubmed/23773349
Pholcodine is an opioid that has been widely used worldwide since 1950 for the treatment of non-productive cough in children and adults. Illicit drug.
Additionally Pholcodine is a marker for sensitization to neuromuscular blocking agents (NMBA) and is intended for use as a diagnostic tool in NMBA-induced anaphylaxis.
CNS Activity
Originator
Sources: Chabrier, P., Guidicelli, R. & Thuillier, J. (1950) Etude chimique, pharmacologique et clinique d’un nouveau skdatif de la toux: la morpholyethyimorphine (M.E.M.). Annales Pharmaceutiques Francais. 8, 26 1-273.
Curator's Comment: Reference was retrieved from: http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2710.1988.tb00502.x/epdf
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P33535|||Q64064 Gene ID: 25601.0 Gene Symbol: Oprm1 Target Organism: Rattus norvegicus (Rat) Sources: http://www.ncbi.nlm.nih.gov/pubmed/1851921 |
|||
Target ID: P35372|||G8XRH8|||Q5TDA1|||Q9UN57 Gene ID: 4988.0 Gene Symbol: OPRM1 Target Organism: Homo sapiens (Human) Sources: http://www.ebi.ac.uk/chebi/searchId.do?chebiId=53579 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Pholcodine Linctus B.P. Approved UseCough |
|||
Diagnostic | ImmunoCAP® Allergen c261 Approved UseAnaphylaxis to neuromuscular blocking agents |
PubMed
Title | Date | PubMed |
---|---|---|
Angle closure risk from proprietary medicines. | 2001 Apr |
|
Impurity profiling of pholcodine by liquid chromatography electrospray ionization mass spectrometry (LC-ESI-MS). | 2002 Jan |
|
Interpretation of GC-MS opiate results in the presence of pholcodine. | 2002 Jun 25 |
|
Enzyme immunoassay validation for the detection of buprenorphine in urine. | 2003 Mar |
|
Comparative efficacy and tolerability of pholcodine and dextromethorphan in the management of patients with acute, non-productive cough : a randomized, double-blind, multicenter study. | 2006 |
|
Site-specific acid-base properties of pholcodine and related compounds. | 2006 Nov |
|
Pholcodine exposure raises serum IgE in patients with previous anaphylaxis to neuromuscular blocking agents. | 2007 Dec |
|
The pholcodine story. | 2009 Aug |
|
Suspected anaphylactic reactions associated with anaesthesia. | 2009 Feb |
|
On the origin and specificity of antibodies to neuromuscular blocking (muscle relaxant) drugs: an immunochemical perspective. | 2009 Mar |
|
Pholcodine caused anaphylaxis in Sweden 30 years ago. | 2009 May |
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m8711
Created by
admin on Sat Dec 16 10:03:31 GMT 2023 , Edited by admin on Sat Dec 16 10:03:31 GMT 2023
|
PRIMARY | Merck Index | ||
|
SUB52587
Created by
admin on Sat Dec 16 10:03:31 GMT 2023 , Edited by admin on Sat Dec 16 10:03:31 GMT 2023
|
PRIMARY | |||
|
100000133620
Created by
admin on Sat Dec 16 10:03:31 GMT 2023 , Edited by admin on Sat Dec 16 10:03:31 GMT 2023
|
PRIMARY | |||
|
86278131
Created by
admin on Sat Dec 16 10:03:31 GMT 2023 , Edited by admin on Sat Dec 16 10:03:31 GMT 2023
|
PRIMARY | |||
|
538VG8KNRX
Created by
admin on Sat Dec 16 10:03:31 GMT 2023 , Edited by admin on Sat Dec 16 10:03:31 GMT 2023
|
PRIMARY | |||
|
6254-99-5
Created by
admin on Sat Dec 16 10:03:31 GMT 2023 , Edited by admin on Sat Dec 16 10:03:31 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD